Latest News & Updates

Breaking News

  • 23 hours ago

  • Vaibhavi M.

Sanofi Gains Japan Approval for Sarclisa Subcutaneous Formulation in Multiple Myeloma
Breaking News
3PBIOVIAN Launches AAVion Platform to Address CMC and Commercial Sustainability Risks in AAV Gene Therapy Manufacturing

Vaibhavi M.

Other trending news you may like to read

Sanofi Gains Japan Approval for Sarclisa Subcutaneous Formulation in Multiple Myeloma

Sanofi's Sarclisa SC gains Japan approval for multiple myeloma; CirCLIQ on-body injector application remains under review.

Vaibhavi M.

Pharma Now

3PBIOVIAN Launches AAVion Platform to Address CMC and Commercial Sustainability Risks in AAV Gene Therapy Manufacturing

3PBIOVIAN's AAVion® platform targets CMC compliance and cost-of-goods risks in AAV gene therapy manufacturing amid rising regulatory scrutiny.

Vaibhavi M.

Pharma Now

3PBIOVIAN Outlines GMP Scale-Up Pitfalls for Recombinant Protein Programs Ahead of IND Filing

3PBIOVIAN identifies documentation gaps and scale-up failures as the leading causes of GMP delays in recombinant protein programs ahead of IND filing.

Vaibhavi M.

Pharma Now

Axcelead Presents Multi-Cell-Line Proteomics Platform for TPD Off-Target Safety Assessment at JSOT 2026

Axcelead presents a multi-cell-line proteomics platform for TPD off-target safety assessment at JSOT 2026, detecting ~10,000 proteins across a human-derived panel.

Simantini Singh Deo

Pharma Now